Sonia T. Oskouei, PharmD: Biosimilars and Misinformation

Sonia T. Oskouei, PharmD, vice president of innovation and solution development at Premier Inc, discusses biosimilars and misinformation.


So, it is hard to manage all of the information that’s out there. Understandably, there’s a lot of different data sources and sites where you can get information, so to manage it all alone is a challenge. But there’s different information out there that talks about aspects of biosimilars, from interchangeability to extrapolation. When it’s out there, it could cause a misunderstanding about biosimilars, whether it’s intentional or not. So that’s, again, the need for education from a patient and provider level to help clarify any of those aspects with biosimilars.